Agharazii M, Marcotte J, Boucher D, Noël R, Lebel M
CHUQ, L'Hôtel-Dieu de Québec Hospital, and Department of Medicine, Laval University, Québec, Canada.
Am J Nephrol. 1999;19(3):373-6. doi: 10.1159/000013480.
Nephrotoxicity has recently been reported with the use of 5-aminosalicylic acid (5-ASA) which has structural similarities to phenacetin and aspirin. The present paper describes 2 cases of interstitial nephritis and 1 case of end-stage failure associated with 5-ASA treatment. The first patient presented with severe renal failure which was partially reversed with 5-ASA discontinuation and steroid therapy. The second had severe renal failure (serum creatinine 469 mmol/l) but renal function stabilized with 5-ASA withdrawal. The third patient had end-stage renal failure and underwent hemodialysis and a successful kidney transplant.
最近有报道称,使用与非那西丁和阿司匹林结构相似的5-氨基水杨酸(5-ASA)会导致肾毒性。本文描述了2例与5-ASA治疗相关的间质性肾炎病例和1例终末期肾衰竭病例。首例患者出现严重肾衰竭,停用5-ASA并进行类固醇治疗后部分缓解。第二例患者也出现严重肾衰竭(血清肌酐469 mmol/l),但停用5-ASA后肾功能稳定。第三例患者为终末期肾衰竭,接受了血液透析并成功进行了肾移植。